Skip to main content
TipRanks
Go Ultimate75% OFF

Lantern Pharma (LTRN) Drug Pipeline

343 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Lp-284Advanced Solid Tumor, Relapsed Or Refractory LymphomasPhase IRecruitingSafety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid TumorsNov 03, 2023―
Olaparib, Spironolactone, Lp-184Advanced Solid Tumor, Pancreatic Adenocarcinoma, Nsclc, Metastatic Solid Tumor, Tnbc - Triple-Negative Breast Cancer, Gbm, Ddr Gene Mutationphase1AndPhase2RecruitingStudy of LP-184 in Patients With Advanced Solid TumorsJun 23, 2023―
Pemetrexed, Carboplatin, Lp-300Carcinoma, Non-small-cell Lung, Adenocarcinoma Of LungPhase IIRecruitingA Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung AdenocarcinomaJul 06, 2022―
Irofulven, Prednisolone 10 MgMetastatic Castration-Resistant Prostate Cancer PatientsPhase IICompletedIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Aug 21, 2018―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lantern Pharma, Inc. (LTRN) have in its pipeline
Lantern Pharma LTRN is currently developing the following drugs: Lp-284, Olaparib, Spironolactone, Lp-184, Pemetrexed, Carboplatin, Lp-300, Irofulven, Prednisolone 10 Mg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.